medigraphic.com
Revista Médica Sinergia

2023, Number 01

<< Back Next >>

Revista Médica Sinergia 2023; 8 (01)

Menopause update and hormone replacement therapy

Guerrero HC, Chacón CNV, Pizarro MM

Language: Spanish
References: 17
Page:
PDF size: 149.46 Kb.


ABSTRACT

Menopause is the cessation of a woman's menstrual periods, diagnosed in retrospect, once twelve consecutive months of amenorrhea have elapsed. It occurs due to atresia of the ovarian follicles and the decrease in their ability to produce estrogens due to the stimulation of follicle-stimulating and luteinizing hormones.
The most common signs and symptoms are hot flashes, osteoporosis, increased cardiovascular risk, and genitourinary disorders.
The decrease in estrogen production is the cause of the symptoms, so it is important to take hormonal and non-hormonal treatment into account, since the former is not always going to be indicated for all patients. It is essential to individualize each case and thus achieve quality of life for postmenopausal women.


REFERENCES

  1. Ayora D, Guzmán M, Sánchez M. Conocimientos y mitos de la menopausia. Enfermería investiga. 2018;3(4):198-202.

  2. Capote M, Segreso A, Gómez O. Climaterio y menopausia. Revista cubana de medicina general integral. 2011;27(4):543-557. Disponible a partir de: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252011000400013&lng=es

  3. Torres A, Torres J. Climaterio y menopausia. Departamento de Integración de Ciencias Médicas. 2018;61(2):51-58. Disponible a partir de: http://www.scielo.org.mx/pdf/facmed/v61n2/2448-4865-facmed-61-02-51.pdf

  4. Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility (9th ed.). 2020. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.

  5. Vásquez A. Menopausia, terapia de reemplazo hormonal y riesgo cardiovascular. Asociación Colombiana de Menopausia. 2018;40(3):372-373. Disponible a partir de: http://www.revistamedicina.net/ojsanm/index.php/Medicina/article/view/1378/1690

  6. Harlow S, Gass M, Hall J, Lobo R, Maki P, Rebar R, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Available from: https://pubmed.ncbi.nlm.nih.gov/22344196/

  7. Zurita V. La menopausia, ¿edad crítica? Anales de la Real Academia de Medicina y Cirugía de Valladolid. 2017;1(54):115-136. Disponible a partir de: https://dialnet.unirioja.es/servlet/articulo?codigo=7140184

  8. Palacios S, Cancelo M, Gonzáles S, Manubens M, Sánchez R. Síndrome genitourinario de la menopausia: recomendaciones de la Sociedad Española de Ginecología y Obstetricia. Revista Oficial de la Sociedad Española de Ginecología y Obstetricia. 2019;62(2):141-148. Disponible a partir de: https://sego.es/documentos/progresos/v62-2019/n2/09-AE_Sindrome-menopausia.pdf

  9. Ayala F, Ayala D, Figueroa L, Carranza A, et al. Síndrome genitourinario de la menopausia: clínica y manejo. Revista Peruana de Investigación Materno Perinatal. 2019;6(1):66–73. Doi: https://doi.org/10.33421/inmp.201780

  10. Roldán G, Gómez G. Síntomas vasomotores en la menopausia: una mirada a la fisiología. Revista Colombiana de Menopausia. 2020;26(2):7-15. Disponible a partir de: https://asomenopausia.com/r/26_2.pdf#page=8

  11. Turiño M, Colomé T, Fuentes E, Palmas S. Symptoms and diseases associated with climacteric and menopause. Revista Científica Villa Clara. 2019;23(2):116-124. Disponible a partir de: http://scielo.sld.cu/scielo.php?pid=S102930432019000200116&script=sci_arttext&tlng=en

  12. Fuentes F, Campos C, Doren A. Enfrentamiento de la osteoporosis postmenopáusica en la consulta de ginecológica. Revista Chilena de Obstetricia y Ginecología. 82(6):639-648. Disponible a partir de: https://www.scielo.cl/scielo.php?pid=S0717-75262017000600639&script=sci_arttext&tlng=en

  13. Cedeño J, Martin D, Pérez A, Riera G. Metabolismo óseo y osteoporosis. Rev Obst Ginecol Venez. 2018;78(1):81-99. Disponible a partir de: https://www.sogvzla.org/wp-content/uploads/2022/04/11Capitulo7.pdf

  14. Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, et al. Edogenous Sex Hormones and Incident Cardiovascular Disease in Post-menopausal women. Journal of American College of Cardiology. 2018;71(22):2555-2566. Disponible a partir de: https://www.sciencedirect.com/science/article/pii/S0735109718343614?via%3Dihub%0b14.%20https://pubmed.ncbi.nlm.nih.gov/34432008/

  15. Genazzani A, Monteleone P, Ginannini A, Simoncini T. Hormone therapy in the posmenopausal years: considering benefits andrisk in clinical practice. Hum Reprod Update. 2021;27(6):1115-1150. Available from: https://pubmed.ncbi.nlm.nih.gov/34432008/

  16. Sánchez F. Terapia hormonal de la menopausia en el año 2021. Revista AGOG. 2021;3(3):88-103. Disponible a partir de: https://docs.bvsalud.org/biblioref/2021/11/1344264/04.pdf

  17. Svatikova A, Hayes S. Menopause and menopausal hormone therapy in women: cardiovascular benefits and risk. Revista Colombiana de Cardiología. 2018;25(1):30-33. Disponible a partir de: https://www.rccardiologia.com/previos/RCC%202018%20Vol.%2025/RCC_2018_25_S1/RCC_2018_25_S1_030-033.pdf




2020     |     www.medigraphic.com